Anzeige
Mehr »
Donnerstag, 12.02.2026 - Börsentäglich über 12.000 News
Top-Ergebnisse: 1,75 g/t Gold über 30,4 Meter + massives Tagebau-Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41QAA | ISIN: CA74143C1068 | Ticker-Symbol: 18H0
Frankfurt
12.02.26 | 08:00
0,014 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
PREVECEUTICAL MEDICAL INC Chart 1 Jahr
5-Tage-Chart
PREVECEUTICAL MEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0030,02222:18

Aktuelle News zur PREVECEUTICAL MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
PREVECEUTICAL MEDICAL Aktie jetzt für 0€ handeln
MoPreveceutical Medical Inc: Preveceutical files CNS drug delivery patent2
MoPreveCeutical Medical Inc.: PreveCeutical Announces Filing of Patent for Delivery of CNS-Active Agents193Vancouver, British Columbia--(Newsfile Corp. - February 9, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is pleased to announce it...
► Artikel lesen
04.12.25Preveceutical Medical Inc: Preveceutical gets Australian patent for pain therapy3
04.12.25PreveCeutical Medical Inc.: PreveCeutical Announces Grant of Patent for Innovative Pain Therapy Technology239Vancouver, British Columbia--(Newsfile Corp. - December 4, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCID: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is pleased to announce that...
► Artikel lesen
27.11.25XFRA NEW INSTRUMENTS AVAILABLE ON 27.11.2025486The following instruments on XETRA do have their first trading 27.11.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 27.11.2025 Aktien 1 CNE100003KK7 Rizhao Port Jurong Co....
► Artikel lesen
26.11.25Preveceutical Medical Inc: Preveceutical, BioGene complete plan of arrangement3
26.11.25XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 26.11.20251.048The following instruments on Boerse Frankfurt do have their last trading day on 26.11.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 26.11.2025ISIN NameCA74141E1043 PREVECEUTICAL...
► Artikel lesen
26.11.25XFRA ISIN CHANGE739Einstellung Aufnahme ISIN Name CCP bis Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenAU000000VG15 Regal Partners Global Investments Ltd. 26.11.2025 AU0000434920 Regal Partners Global Investments...
► Artikel lesen
26.11.25PreveCeutical Medical Inc.: PreveCeutical Medical and BioGene Therapeutics Announce Closing of Plan of Arrangement298NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - November 26, 2025) - PreveCeutical Medical Inc. (CSE:...
► Artikel lesen
25.11.25XFRA 18H: AUSSETZUNG/SUSPENSION157DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPREVECEUTICAL MED....
► Artikel lesen
24.11.25Preveceutical Medical Inc: Preveceutical Medical distribution, reclassification3
24.11.25CSE Bulletin: Notice of Distribution and Reclassification - PreveCeutical Medical Inc. (PREV)320Toronto, Ontario--(Newsfile Corp. - Le 24 novembre/November 2025) - PreveCeutical Medical Inc. ("PreveCeutical") has announced the effective date of the reclassification as well as the previously...
► Artikel lesen
20.11.25Preveceutical Medical Inc: Preveceutical to close BioGene deal effective Nov. 242
20.11.25PreveCeutical Medical Inc.: PreveCeutical Provides Clarification of News Release Announcing Update on Plan of Arrangement with BioGene Therapeutics Inc.437Vancouver, British Columbia--(Newsfile Corp. - November 20, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that, further to its...
► Artikel lesen
20.11.25PreveCeutical Medical Inc.: PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.284NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - November 20, 2025) - PreveCeutical Medical Inc. (CSE:...
► Artikel lesen
30.10.25Preveceutical Medical Inc: Preveceutical closes $455k second tranche of placement2
20.10.25PreveCeutical Medical Inc.: PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.310NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - October 20, 2025) - PreveCeutical Medical Inc. (CSE:...
► Artikel lesen
13.10.25PreveCeutical Medical boosts private placement to $1.2M, following shareholder meeting approvals4
11.10.25Preveceutical Medical Inc: Preveceutical hikes placement, releases AGSM results4
10.10.25PreveCeutical Medical Inc.: PreveCeutical Announces Results from Annual General and Special Meeting and Increase to Size of Non-Brokered Private Placement488Vancouver, British Columbia--(Newsfile Corp. - October 10, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that all...
► Artikel lesen
Weiter >>
43 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1